{
    "title": "Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling",
    "abstract": "arXiv:2402.14315v1 Announce Type: cross  Abstract: Structure-based drug design aims at generating high affinity ligands with prior knowledge of 3D target structures. Existing methods either use conditional generative model to learn the distribution of 3D ligands given target binding sites, or iteratively modify molecules to optimize a structure-based activity estimator. The former is highly constrained by data quantity and quality, which leaves optimization-based approaches more promising in practical scenario. However, existing optimization-based approaches choose to edit molecules in 2D space, and use molecular docking to estimate the activity using docking predicted 3D target-ligand complexes. The misalignment between the action space and the objective hinders the performance of these models, especially for those employ deep learning for acceleration. In this work, we propose MolEdit3D to combine 3D molecular generation with optimization frameworks. We develop a novel 3D graph editi",
    "link": "https://arxiv.org/abs/2402.14315",
    "context": "Title: Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling\nAbstract: arXiv:2402.14315v1 Announce Type: cross  Abstract: Structure-based drug design aims at generating high affinity ligands with prior knowledge of 3D target structures. Existing methods either use conditional generative model to learn the distribution of 3D ligands given target binding sites, or iteratively modify molecules to optimize a structure-based activity estimator. The former is highly constrained by data quantity and quality, which leaves optimization-based approaches more promising in practical scenario. However, existing optimization-based approaches choose to edit molecules in 2D space, and use molecular docking to estimate the activity using docking predicted 3D target-ligand complexes. The misalignment between the action space and the objective hinders the performance of these models, especially for those employ deep learning for acceleration. In this work, we propose MolEdit3D to combine 3D molecular generation with optimization frameworks. We develop a novel 3D graph editi",
    "path": "papers/24/02/2402.14315.json",
    "total_tokens": 714,
    "translated_title": "通过三维分子生成的预训练和采样进行基于结构的药物设计",
    "translated_abstract": "结构基药物设计旨在在先验知识下生成具有高亲和力的配体，并了解3D靶标结构。现有方法要么使用条件生成模型来学习给定目标结合位点的3D配体分布，要么迭代修改分子以优化基于结构的活性估计器。本文提出将3D分子生成与优化框架相结合，以解决现有基于优化的方法在编辑分子时选择在2D空间中，并使用分子对接来估计活性的问题。",
    "tldr": "本研究提出了MolEdit3D，将3D分子生成与优化框架相结合，解决了现有基于优化的方法编辑分子时选择在2D空间中的问题。",
    "en_tdlr": "This study introduces MolEdit3D, which combines 3D molecular generation with optimization frameworks to address the issue of existing optimization-based methods editing molecules in 2D space."
}